Zonisamide as add-on treatment for children with epilepsy
Part of Brain & nervous system clinical trials.
This trial tests adding zonisamide to the current epilepsy medication for children aged 1 to 14 who still have focal seizures. The goal is to see if the combination works better and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 14 years old
- You have been taking one seizure medication for at least 4 weeks and it is not fully controlling your seizures
- You have had at least 2 seizures that start in one part of the brain and spread to both sides in a month
- You have not taken zonisamide before
- You are not allergic to sulfa drugs or zonisamide
- You do not have a history of serious mental health conditions or certain other illnesses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a liquid medication called ZONISADE (zonisamide) for children aged 1 month to 17 years who have partial-onset seizures. It aims to see how the drug works in the body and how safe it is.
This trial tests a new capsule, JZP926, to see if it reduces myoclonic seizures in people with juvenile myoclonic epilepsy (JME). It may offer a new treatment option if you have at least 4 myoclonic seizure days per month and meet other criteria.
This Phase 3 trial tests XEN1101 added to your current seizure medicines for people with primary generalized tonic-clonic seizures. It’s for seizures that have not fully stopped even after trying at least two appropriate medicines.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This trial tests if adding cannabidiol (CBD) to your child's current seizure medicines can reduce seizures. It uses a personalized approach to see if CBD works for each child.
This study tests an experimental drug called zorevunersen for people with Dravet syndrome. It aims to see if the drug can reduce seizures and improve safety.
Hear when a new Epilepsies, Partial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.